Skip to content

Italian Registry of Minimally Invasive Pancreatic Surgery

Italian Registry of Minimally Invasive Pancreatic Surgery (IGOMIPS)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06381362
Acronym
IGOMIPS
Enrollment
2300
Registered
2024-04-24
Start date
2019-02-28
Completion date
2029-02-28
Last updated
2024-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Surgery

Brief summary

Assess the prevalence of minimally invasive pancreatic surgery in the country and its outcomes

Detailed description

Since 1994, when the first pancreatectomy surgeries, distal and proximal, conducted minimally invasively, were published, efforts have been made to understand the value of this approach in the context of a surgery as complex and burdened with specific complications as pancreatic surgery. The adoption of such an approach with regard to pancreatic surgery has been less rapid and parceled out than in other surgical fields and not supported by a large body of scientific publications. However, worldwide, referral centers for pancreatic surgery routinely use the minimally invasive approach in selected cases, and its diffusion has recently shown a marked increase. Even in Italy, a recent survey promoted by some of the major surgical societies showed a fair diffusion of the use of the minimally invasive approach in pancreatic surgery but with extremely variable ways and uses in the different territorial realities with evident and potentially risky paradoxes. Monitoring the diffusion of minimally invasive pancreatic surgery, the methods of application and the results of this approach has become of primary importance and for this reason the foundation of a national registry has been proposed by several scientific surgical societies. This study aims to investigate what is the real diffusion of minimally invasive techniques in Italy and what postoperative outcomes the adoption of this approach generates.

Interventions

PROCEDUREMinimally invasive pancreatic surgery

Minimally invasive pancreatic surgery

Sponsors

Associazione Italiana per lo Studio del Pancreas
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Age \> 18 years; * Underwent minimally invasive pancreatic surgery

Exclusion criteria

* Pregnant woman * Minor or unable to give informed consent

Design outcomes

Primary

MeasureTime frameDescription
Postoperative short-term outcomes90 daysany complication graded according to Clavien-Dindo classification
Long-term oncological outcomes2 yearsDisease recurrence or disease related death

Secondary

MeasureTime frameDescription
Rate of cases that after a minimally invasive approach had to be converted to and open approachIntraoperativeIntraoperative conversion to open surgery for any reason
Surgeon learning curveIntraoperativeVariation of surgical time according to the registered case-load as operating surgeon and first assistant

Countries

Italy

Contacts

Primary ContactAlessandro Zerbi, Prof.
alessandro.zerbi@hunimed.eu+390282245941

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026